Serena Mandla
CSO at Noa Therapeutics
Experienced innovator in the development, manufacturing, and commercialization of novel small peptides for cardiovascular and skin disease applications
CSO & Co-Founder in Noa Therapeutics
Breaking free from convention, Noa aims to revolutionize treatment options for complex inflammatory skin diseases.
Serena Mandla
CSO at Noa Therapeutics